Literature DB >> 8606072

Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp.

C Chong1, K L Bost, J D Clements.   

Abstract

The use of attenuated Salmonella spp. as live oral vaccine carriers fo r foreign antigens has been extensively studied. We have shown that appropriately prepared nonviable organisms are as effective as viable organisms in eliciting humoral immune responses against a foreign antigen delivered by these vectors. It is not clear how strain viability affects the development of a cell-mediated immune response. In the present study, we demonstrate that BALB/c mice orally immunized with viable attenuated Salmonella spp. were protected against subsequent challenge while animals immunized with killed organisms were not. Protection was correlated with increased production of interleukin-12 (IL-12) p40 mRNA in the Peyer's patches within hours of oral administration. Peritoneal macrophages from lipopolysaccharide (LPS)-responsive and LPS-unresponsive mice were also examined for production of IL-12 p40 mRNA following exposure to the viable or killed attenuated Salmonella carrier. There was dramatic upregulation of IL-12 p40 mRNA following exposure of macrophages to either viable or killed organisms. By 4 h postexposure, viable organisms had induced a 27-fold increase in IL-12 p40 mRNA levels while killed organisms had induced a 9-fold increase in IL-12 p40 mRNA levels. This was observed in macrophages isolated from both LPS-responsive and unresponsive mice. The higher levels of IL-12 induced by viable Salmonella spp. may result in the development of a Th1 response and cell mediated immunity, while the lower levels of IL-12 induced by killed Salmonella spp. may not be sufficient to promote a Th1 response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606072      PMCID: PMC173897          DOI: 10.1128/iai.64.4.1154-1160.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED AND ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES.

Authors:  M T ASHCROFT; J M RITCHIE; C C NICHOLSON
Journal:  Am J Hyg       Date:  1964-03

2.  The genetic mapping of a defective LPS response gene in C3H/HeJ mice.

Authors:  J Watson; K Kelly; M Largen; B A Taylor
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  The response of recombinant inbred strains of mice to bacterial lipopolysaccharides.

Authors:  J Watson; R Riblet; B A Taylor
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

4.  Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin.

Authors:  L M Glode; A Jacques; S E Mergenhagen; D L Rosenstreich
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Genetic control of leucocyte responses to endotoxin.

Authors:  B M Sultzer
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

6.  Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study.

Authors:  D E Bockman; M D Cooper
Journal:  Am J Anat       Date:  1973-04

7.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

8.  Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: an ultrastructural study.

Authors:  R L Owen
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

9.  Controlled field trial of a high-dose oral killed typhoid vaccine in India.

Authors:  C S Chuttani; K Prakash; P Gupta; V Grover; A Kumar
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

10.  Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  18 in total

1.  The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection.

Authors:  R William Depaolo; Rashida Lathan; Barrett J Rollins; William J Karpus
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Limited interleukin-18 response in Salmonella-infected murine macrophages and in Salmonella-infected mice.

Authors:  A Elhofy; K L Bost
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL-12) but minimal secretion of IL-12 as a 70-kilodalton protein in murine macrophages.

Authors:  K L Bost; J D Clements
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections.

Authors:  J K Dybing; N Walters; D W Pascual
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Assessment of Lactobacillus gasseri as a candidate oral vaccine vector.

Authors:  Laura Stoeker; Shila Nordone; Sara Gunderson; Lin Zhang; Akinobu Kajikawa; Alora LaVoy; Michael Miller; Todd R Klaenhammer; Gregg A Dean
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

6.  Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.

Authors:  R Lo-Man; J P Langeveld; E Dériaud; M Jehanno; M Rojas; J M Clément; R H Meloen; M Hofnung; C Leclerc
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance.

Authors:  S Pie; P Truffa-Bachi; M Pla; C Nauciel
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

8.  Interleukin-12 has a role in mediating resistance of murine strains to Tyzzer's disease.

Authors:  R A Van Andel; R R Hook; C L Franklin; C L Besch-Williford; L K Riley
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

9.  Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan.

Authors:  C Lawrence; C Nauciel
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin.

Authors:  T Kincy-Cain; J D Clements; K L Bost
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.